Published in Genet Epidemiol on January 01, 1988
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med (1996) 7.06
Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci U S A (1986) 5.12
An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med (1966) 4.89
Control of specific gene expression in higher organisms. Expression of mammalian genes may be controlled by repressors acting on the translation of messenger RNA. Science (1969) 4.81
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med (1993) 4.03
Deprivation payments to general practitioners: limitations of census data. BMJ (1996) 3.98
Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med (1977) 3.80
Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A (1976) 3.74
Using data from the 1991 census. BMJ (1995) 3.63
Guidelines on the management of common bile duct stones (CBDS). Gut (2008) 3.58
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J Virol (1987) 3.58
Public-health impact of accelerated measles control in the WHO African Region 2000-03. Lancet (2005) 3.36
Early predictors of career achievement in academic medicine. JAMA (1992) 3.35
Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes (1990) 3.34
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
A prospective study of delirium in hospitalized elderly. JAMA (1990) 3.02
Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med (1976) 2.98
The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health (2004) 2.92
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy (2007) 2.88
Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med (1988) 2.80
Interference with granulocyte function by Staphylococcus epidermidis slime. Infect Immun (1986) 2.80
Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77
Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol (1970) 2.62
Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology (1987) 2.53
Postcodes and the 1991 census of population: issues, problems and prospects. Trans Inst Br Geogr (1992) 2.46
On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS (1997) 2.39
Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet (1984) 2.35
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women. J Bone Miner Res (1991) 2.33
The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway. Curr Biol (2001) 2.27
Clinical significance of the recovery of Aspergillus species from the respiratory secretions of cystic fibrosis patients. Pediatr Pulmonol (1996) 2.19
Bactericidal substance from Staphylococcus aureus. Biological properties. J Exp Med (1970) 2.11
Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med (1993) 2.07
Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci (2001) 2.07
Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol (1999) 2.05
Difficulties in recognizing one's own incompetence: novice physicians who are unskilled and unaware of it. Acad Med (2001) 1.98
The running tie-over dressing. Plast Reconstr Surg (2000) 1.96
Synthesis and induction of tyrosine aminotransferase in synchronized hepatoma cells in culture. Proc Natl Acad Sci U S A (1969) 1.95
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience (2001) 1.91
Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med (1994) 1.91
Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg (1990) 1.90
Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain (1997) 1.90
Terpenoid secondary metabolism in Arabidopsis thaliana: cDNA cloning, characterization, and functional expression of a myrcene/(E)-beta-ocimene synthase. Arch Biochem Biophys (2000) 1.89
Isolation of eastern equine encephalitis virus from Aedes albopictus in Florida. Science (1992) 1.89
Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med (1973) 1.89
A novel mechanism for skeletal resistance in uremia. Kidney Int (2000) 1.88
Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J Cell Sci (1999) 1.87
Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res (2000) 1.83
Mimetic relationships between group A streptococci and mammalian tissues. Adv Immunol (1967) 1.83
Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules. Kidney Int (2000) 1.82
Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis (2001) 1.82
Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry (1997) 1.81
Transcriptional regulation of the mosquito vitellogenin gene via a blood meal-triggered cascade. Gene (2001) 1.81
Linking community-based blood pressure measurement to clinical care: a randomized controlled trial of outreach and tracking by community health workers. Am J Public Health (1999) 1.81
Characterization of cytokine-induced hyperalgesia. Brain Res (1994) 1.78
Effect of Bactericidal Substance from Staphylococcus aureus on Group A Streptococci I. Biochemical Alterations. Infect Immun (1970) 1.75
Establishing a workplace antiretroviral therapy programme in South Africa. AIDS Care (2007) 1.75
Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect Immun (2000) 1.73
A multilevel analysis of the effects of rurality and social deprivation on premature limiting long term illness. J Epidemiol Community Health (2001) 1.72
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand. Vaccine (2007) 1.72
Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res (1997) 1.69
Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med (1984) 1.68
What predicts failed cannulation and therapy at ERCP? Results of a large-scale multicenter analysis. Endoscopy (2012) 1.68
Issues in the measurement of satisfaction with treatment. Am J Manag Care (1997) 1.67
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J Clin Invest (1996) 1.64
Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis. J Clin Microbiol (1999) 1.64
Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway. J Exp Med (1976) 1.64
Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis (1999) 1.63
Purification and partial characterization of the nephritis strain-associated protein from Streptococcus pyogenes, group A. J Exp Med (1986) 1.62
Prediction of readmissions after CABG using detailed follow-up data: the Israeli CABG Study (ISCAB) Med Care (1999) 1.62
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med (1980) 1.61
Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol (2000) 1.61
Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett (1995) 1.60
Antigens in Streptococcus mutans cross reactive with human heart muscle. J Dent Res (1976) 1.59
NMR structure of the calreticulin P-domain. Proc Natl Acad Sci U S A (2001) 1.58
Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci U S A (1995) 1.58
The generation of spatial population distributions from census centroid data. Environ Plan A (1989) 1.57
Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation (1999) 1.57
Meningococcal disease in Auckland, July 1992 - June 1994. N Z Med J (1999) 1.55
A suppression of cellular immunity in patients with multiple sclerosis. J Exp Med (1973) 1.55
Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J (1998) 1.54
Thermophoresis of DNA determined by microfluidic fluorescence. Eur Phys J E Soft Matter (2004) 1.54
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int (2007) 1.53
Protein trans-splicing and cyclization by a naturally split intein from the dnaE gene of Synechocystis species PCC6803. J Biol Chem (2000) 1.53
Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood (1986) 1.53
Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995. Am J Trop Med Hyg (1998) 1.52
Linkage of the 1981 and 1991 U.K. censuses using surface modelling concepts. Environ Plan A (1995) 1.52
Cholera on the Texas Gulf Coast. JAMA (1982) 1.50
Investigation on extracellular slime substance produced by Staphylococcus epidermidis. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.49
Tenm, a Drosophila gene related to tenascin, is a new pair-rule gene. EMBO J (1994) 1.48
Association of HL-A 5 and immune responsiveness in vitro to streptococcal antigens. J Exp Med (1975) 1.48
A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacy. Obstet Gynecol (1997) 1.47
Fatal shoulder dystocia: a review of 56 cases reported to the Confidential Enquiry into Stillbirths and Deaths in Infancy. Br J Obstet Gynaecol (1998) 1.46
Simple method for the preparation of streptococcal nucleases. Appl Microbiol (1972) 1.46